IMPACT OF NICORANDIL IN ANGINA: SUBGROUP ANALYSES
Aims: IONA (impact of nicorandil in angina) is a randomised, double blind, placebo controlled trial of nicorandil, with a target dose of 20 mg twice daily. The consistency of benefits seen in subgroups is reported. Methods: The primary composite end point of the study was coronary heart disease deat...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Russo |
| Publié: |
«FIRMA «SILICEA» LLC
2010-08-01
|
| Collection: | Российский кардиологический журнал |
| Sujets: | |
| Accès en ligne: | https://russjcardiol.elpub.ru/jour/article/view/1468 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|